Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and intake effect of EPs 7630 (Pelargonium sidoides root extract) in adults
2013-004977-28Phase 3Completed
- Sponsor
- Schwabe Group
- Start
- Dec 2013
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pelargonium sidoides extract in nasopharyngitis, sponsored by Schwabe Group. Primary endpoint: Occurrence of Adverse Drug Reactions. Started Dec 2013; status: completed.
02
Drugs
pelargonium sidoides extract
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2013-004977-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004977-28.